Published in:
Volume 7 / Year 2018 / Issue 4

Nomenclature for biosimilars; a continuing thorny issue

Page: 141

Abstract: Nomenclature for biosimilars is a controversial issue. In this issue of GaBI Journal, a paper by Sarshad et al. considers the US FDA’s published system for this and concludes… Read More »

Go Back Print